Int. J. Mol. Sci. 2012, 13(6), 7663-7675; doi:10.3390/ijms13067663
Article

Expression of Sox2 and Oct4 and Their Clinical Significance in Human Non-Small-Cell Lung Cancer

1,†email, 2,†email, 1email, 1email, 1email, 1email, 3email and 1,* email
Received: 11 April 2012; in revised form: 15 June 2012 / Accepted: 19 June 2012 / Published: 21 June 2012
(This article belongs to the Special Issue Advances in Molecular Oncology)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Sox2 and Oct4 are transcription factors with the characteristics of regulating self-renewal and differentiation of embryonic stem cell. The aim of this study was to detect the expression of Sox2 and Oct4 and analyze their clinical significance in human non-small-cell lung cancer (NSCLC). Expression of Sox2 and Oct4 were assayed in cancer tissues and their corresponding paracancerous tissues from 44 patients with NSCLC and 21 patients with benign tumors using immunohistochemistry, Western blot, reverse transcription polymerase chain reaction (RT-PCR). The correlation between the expression of Sox2 and Oct4 and tumor type, grade and prognosis and the utility of the two genes in discriminating between benign and malignant tumors were analyzed as well. The results showed that Sox2 and Oct4 positive staining was only seen in the nuclei of cancer cells but not in either the precancerous tissues or benign tumor tissues by immunohistochemistry (p < 0.01). Furthermore, in the lung cancer tissue, the positive rate for Sox2 and Oct4 was 70.5% and 54.5%, respectively. Meanwhile, clinicopathological correlations showed that the Oct4 expression level was significantly associated with poorer differentiation and higher TNM stage of the cancer (p < 0.05). Western blot and RT-PCR analysis showed similar results to immunohistochemistry. Follow-up analysis revealed that expression of Oct4 was significantly associated with poor prognosis of lung cancer. The conclusion is that Sox2 and Oct4 may act as the promising unit markers in directing NSCLC diagnosis and therapy. Also, Oct4 can be regarded as a novel predictor of poor prognosis for NSCLC patients undergoing resection.
Keywords: NSCLC; Sox2; Oct4; immunohistochemistry; RT-PCR; Western blot
PDF Full-text Download PDF Full-Text [407 KB, uploaded 19 June 2014 04:19 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Li, X.; Wang, J.; Xu, Z.; Ahmad, A.; Li, E.; Wang, Y.; Qin, S.; Wang, Q. Expression of Sox2 and Oct4 and Their Clinical Significance in Human Non-Small-Cell Lung Cancer. Int. J. Mol. Sci. 2012, 13, 7663-7675.

AMA Style

Li X, Wang J, Xu Z, Ahmad A, Li E, Wang Y, Qin S, Wang Q. Expression of Sox2 and Oct4 and Their Clinical Significance in Human Non-Small-Cell Lung Cancer. International Journal of Molecular Sciences. 2012; 13(6):7663-7675.

Chicago/Turabian Style

Li, Xinxin; Wang, Jinguang; Xu, Zhiyun; Ahmad, Aftab; Li, Encheng; Wang, Yuan; Qin, Suli; Wang, Qi. 2012. "Expression of Sox2 and Oct4 and Their Clinical Significance in Human Non-Small-Cell Lung Cancer." Int. J. Mol. Sci. 13, no. 6: 7663-7675.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert